IB Geography F.4.3 Prevention and Treatment in Managing Disease Notes

Transmission and Available Technology Shape the Prevention-Treatment Balance

1. Prevention reduces the chance that illness begins or spreads, while treatment acts after a person becomes ill or a condition is detected.
2. Vaccination, sanitation, vector control, safer behaviour and regulation can interrupt exposure or transmission.
3. Medicines, surgery, rehabilitation and long-term clinical management reduce symptoms, complications or mortality after disease occurs.
4. A vaccine-preventable infection supports investment in prevention because high coverage can protect individuals and reduce transmission.
5. A disease without a vaccine may depend more on sanitation, behaviour change, surveillance and rapid treatment.
6. Chronic non-communicable diseases often require lifelong treatment, even when tobacco control, diet and physical activity reduce future incidence.
7. The suitable mix therefore depends on cause, transmission route, latency, available science and whether risk can be changed before illness occurs.

Prevention Can Reach Populations Before Symptoms Appear

1. Clean water and sanitation protect whole settlements from faecal contamination without waiting for each infected person to reach a clinic.
2. Mosquito nets, habitat management and insecticide spraying reduce contact between vectors and people.
3. Vaccination reduces the susceptible population and can make transmission less likely when coverage is sufficiently high.
4. Tobacco taxes, smoke-free laws and advertising restrictions alter the environment in which individual health choices are made.
5. Screening occupies a boundary between prevention and treatment because it detects risk or disease early enough to reduce later harm.
6. Population measures can be cost-effective, but benefits may appear slowly and the people protected are less visible than patients receiving treatment.
7. Prevention can also fail when mistrust, weak enforcement or missing infrastructure leaves the highest-risk groups unprotected.

Treatment Produces Visible Benefits but Depends on Continuing Access

1. Effective treatment can prevent death, shorten infectious periods and allow people to return to work, education and care responsibilities.
2. Prompt treatment of malaria reduces severe disease, while long-term antiretroviral therapy allows many people with HIV to live healthy lives and reduces transmission risk.
3. Hypertension and diabetes management prevent complications only when diagnosis, medicines, monitoring and behaviour support continue.
4. Hospitals attract political attention because patients, staff and equipment are visible, while avoided illness is difficult to display.
5. Treatment-heavy systems can become expensive when they address complications that earlier prevention could have reduced.
6. Treatment remains indispensable where prevention is incomplete, scientifically unavailable or unable to reverse existing illness.

Social Marginalisation Can Block Both Strategies

1. Social marginalisation occurs when institutions and social relations exclude a group from resources, rights, recognition or decision-making.
2. Prevention campaigns tied to schools, registered addresses or digital records can miss homeless people, undocumented migrants and mobile populations.
3. People who fear discrimination or official contact may avoid vaccination, screening or disease reporting.
4. Clinic-based treatment excludes people who cannot pay, travel, leave work, obtain childcare or cross a controlled border.
5. Language, gender norms and disability can reduce the practical accessibility of both public information and clinical care.
6. A formally universal programme can therefore widen inequality when the easiest groups are reached first and the most exposed remain outside it.

Government Priorities Influence Which Lives and Timescales Receive Funding

1. A finance ministry may favour prevention when it reduces future expenditure, while an elected government may favour a visible hospital with immediate political value.
2. Donor funding can prioritise a named infectious disease even when local clinics face a broader burden of chronic illness.
3. User fees shift treatment cost to households and can delay care until illness becomes more severe and expensive.
4. Regulation can prevent exposure at scale, but industries affected by taxes or advertising restrictions may oppose it.
5. Emergency spending can expand treatment quickly while displacing routine vaccination, maternal care or chronic-disease management.
6. Budget choices reveal which population, disease and time horizon the government values most.

An Effective Health System Combines Prevention and Treatment

1. Primary care can vaccinate, screen, diagnose and manage chronic disease through the same local network.
2. Surveillance connects both sides by detecting where prevention is failing and where treatment demand is rising.
3. Treatment data can identify uneven outcomes and direct preventive work toward places or groups with persistent risk.
4. Prevention reduces the future caseload, while treatment protects people who are already ill or remain exposed.
5. The balance should change as transmission, scientific options, age structure and health-system capacity change.
6. A strong judgement specifies the disease and population because no universal prevention-treatment ratio exists.